MedTrace Logo

Acute Effects of Alpha-glycerylphosphorylcholine (A-GPC) on Lower Body Muscular Performance.

NCT07397273 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2026-02-09

No results posted yet for this study

Summary

The purpose of the present study was to examine the effectiveness of acute A-GPC supplementation on upper and lower body muscular strength, endurance, power, and global levels of activation.

Conditions

  • Healthy Adult Participants

Interventions

DIETARY_SUPPLEMENT

L-Alpha glycerylphosphorylcholine

Oral, 900 mg, single dose study

DIETARY_SUPPLEMENT

Microcrystalline Cellulose

Oral, 900 mg, single dose study

Sponsors & Collaborators

  • Mayo Clinic

    collaborator OTHER

  • Northern Illinois University

    lead OTHER

Principal Investigators

  • Clayton Camic, PHD · Northern Illinois University

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
19 Years
Max Age
29 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-03-16
Primary Completion
2026-05-16
Completion
2026-05-16

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07397273 on ClinicalTrials.gov